BG30021A3 - Method for obtaining of imidazoisohinolin- dion - Google Patents

Method for obtaining of imidazoisohinolin- dion

Info

Publication number
BG30021A3
BG30021A3 BG7840381A BG4038178A BG30021A3 BG 30021 A3 BG30021 A3 BG 30021A3 BG 7840381 A BG7840381 A BG 7840381A BG 4038178 A BG4038178 A BG 4038178A BG 30021 A3 BG30021 A3 BG 30021A3
Authority
BG
Bulgaria
Prior art keywords
imidazoisohinolin
dion
obtaining
Prior art date
Application number
BG7840381A
Other languages
Bulgarian (bg)
English (en)
Inventor
Austel
Kutter
Haider
Eberlein
Kobinger
Lillie
Diederen
Haurmann
Original Assignee
Dr. Karl Thomae Gmbh,De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772732951 external-priority patent/DE2732951A1/de
Priority claimed from DE2732906A external-priority patent/DE2732906C2/de
Application filed by Dr. Karl Thomae Gmbh,De filed Critical Dr. Karl Thomae Gmbh,De
Publication of BG30021A3 publication Critical patent/BG30021A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG7840381A 1977-07-21 1978-07-12 Method for obtaining of imidazoisohinolin- dion BG30021A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772732951 DE2732951A1 (de) 1977-07-21 1977-07-21 Neue imidazo-isochinolin-dione
DE2732906A DE2732906C2 (de) 1977-07-21 1977-07-21 In 5-Stellung durch einen Aminoalkylrest substituierte Imidazo-isochinolin-dione, Verfahren zu ihrer Herstellung und Arzneimittel

Publications (1)

Publication Number Publication Date
BG30021A3 true BG30021A3 (en) 1981-03-16

Family

ID=25772367

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7840381A BG30021A3 (en) 1977-07-21 1978-07-12 Method for obtaining of imidazoisohinolin- dion

Country Status (29)

Country Link
US (1) US4176184A (de)
JP (1) JPS5422400A (de)
AT (1) AT366383B (de)
AU (1) AU519769B2 (de)
BG (1) BG30021A3 (de)
CA (1) CA1091232A (de)
CH (1) CH642367A5 (de)
CS (1) CS204032B2 (de)
DD (1) DD137933A5 (de)
DK (1) DK323378A (de)
ES (4) ES471254A1 (de)
FI (1) FI64371C (de)
FR (1) FR2398069A1 (de)
GB (1) GB2002751B (de)
GR (1) GR65025B (de)
HK (1) HK20685A (de)
HU (1) HU181000B (de)
IL (1) IL55168A (de)
IT (1) IT1107653B (de)
LU (1) LU80001A1 (de)
NL (1) NL7807760A (de)
NO (1) NO149314C (de)
NZ (1) NZ187916A (de)
PL (1) PL110398B1 (de)
PT (1) PT68329A (de)
SE (1) SE441746B (de)
SG (1) SG185G (de)
SU (1) SU688129A3 (de)
YU (1) YU40340B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP2558707Y2 (ja) * 1986-06-25 1998-01-14 松下電工 株式会社 蓄積式防排煙受信機
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
DE19918211A1 (de) 1999-04-22 2000-10-26 Basf Ag Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung
EP1222187B1 (de) * 1999-10-06 2004-09-22 Boehringer Ingelheim Pharmaceuticals Inc. Heterocyclische verbindungen verwendbar als tyrosinkinase inhibitoren
US6506769B2 (en) * 1999-10-06 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
CA2417635C (en) 2000-08-11 2008-02-05 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
WO2005042530A1 (en) * 2003-10-30 2005-05-12 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368009B (de) * 1971-09-16 1974-06-17 Kabi Ab
US3878206A (en) * 1973-06-06 1975-04-15 Morton Norwich Products Inc 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines

Also Published As

Publication number Publication date
CH642367A5 (de) 1984-04-13
FI64371C (fi) 1983-11-10
GR65025B (en) 1980-06-16
AT366383B (de) 1982-04-13
FR2398069A1 (fr) 1979-02-16
FR2398069B1 (de) 1981-05-22
NO149314B (no) 1983-12-19
ES471254A1 (es) 1979-10-01
PL110398B1 (en) 1980-07-31
PL208543A1 (pl) 1979-05-21
DK323378A (da) 1979-01-22
IT7850337A0 (it) 1978-07-17
NL7807760A (nl) 1979-01-23
AU519769B2 (en) 1981-12-24
ES476166A1 (es) 1979-06-01
GB2002751B (en) 1982-02-10
ATA498878A (de) 1981-08-15
GB2002751A (en) 1979-02-28
NZ187916A (en) 1981-05-01
AU3821078A (en) 1980-01-24
JPS5422400A (en) 1979-02-20
ES476167A1 (es) 1979-04-16
HK20685A (en) 1985-03-29
NO149314C (no) 1984-03-28
FI782011A (fi) 1979-01-22
ES476168A1 (es) 1979-05-16
YU40340B (en) 1985-12-31
IL55168A (en) 1981-09-13
LU80001A1 (de) 1979-09-06
YU174778A (en) 1983-02-28
PT68329A (de) 1978-08-01
SE7808018L (sv) 1979-01-22
IL55168A0 (en) 1978-09-29
SU688129A3 (ru) 1979-09-25
CA1091232A (en) 1980-12-09
US4176184A (en) 1979-11-27
CS204032B2 (en) 1981-03-31
FI64371B (fi) 1983-07-29
DD137933A5 (de) 1979-10-03
JPS6112912B2 (de) 1986-04-10
NO782498L (no) 1979-01-23
SG185G (en) 1985-06-14
SE441746B (sv) 1985-11-04
IT1107653B (it) 1985-11-25
HU181000B (en) 1983-05-30

Similar Documents

Publication Publication Date Title
BG31225A3 (en) Method for obtaining of acilanilid derivatives
BG30015A3 (en) Method for obtaining of triphenylalkene derivatives
BG28703A3 (en) Method of obtaining of momatostatine derivatives
BG31945A3 (en) Method for obtaining of 4- acylamino- phenyl- ethanolamines
JPS5422208A (en) Method of photogravuring
BG28706A4 (en) Method of obtaining of n- substituated halogenacetamilides
BG28700A3 (en) Method of obtaining of alkylendiamine derivatives
BG32853A3 (en) Method for obtaining of 1- oxadethiacephalosporine
BG30927A3 (en) Method for obtaining of trans- 4- alpha- phenyl- octahydro- 1h- 2- pyridine
BG30175A4 (en) Method of obtaining of pyridon compounds
BG30021A3 (en) Method for obtaining of imidazoisohinolin- dion
BG28574A3 (en) Method of obtaining of 4- diphenylmethylene- 1- hydroxybensylpiperidin
BG32117A4 (en) Method for obtaining of oleandomicine
BG33283A3 (en) Method for obtaining of pyridazinylhydrazon
BG31947A3 (en) Method for obtaining of acetidine derivatives
BG30017A3 (en) Method for obtaining of bensoilcarbrmid
BG29285A3 (en) Method of obtaining of 3- di- n- propyl- acetoxy- benzodiazepin- 2- on
BG33157A3 (en) Method for obtaining of triazon derivatives
JPS53119833A (en) Method of purieying ppphenylenediamine
JPS53112894A (en) Method of etherizing
BG33290A3 (en) Method for obtaining of oxazolinazetidine
BG33293A3 (en) Method for obtaining of 4- dezacetyldimer indoldihydrondol
SU974757A1 (ru) Способ получения 1-оксиадамантан-4-она
BG28985A3 (en) Method of obtaining of dicyanil- hydrazonmalononitrils
BG28705A4 (en) Method of obtaining of tetradecaptetides